RFG Advisory, LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1633387 BIRMINGHAM, AL

Position in VRTX

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$987,995

+$244,506 QoQ

Shares Held

1,989

+19.5% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

#77

of 223 holders

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 0.4524886877828055.ToString("F0")% Shared 0.ToString("F0")% None 99.5475113122172.ToString("F0")%

Healthcare · as of Jun 30, 2026

RFG Advisory, LLC holds $11,845,532 across 11 Biotechnology names. VRTX ranks #4 (8.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VKTX	Viking Therapeutics, Inc.	142,790	$5,570,237
2	CPRX	Catalyst Pharmaceuticals, Inc.	85,989	$2,702,634
3	HALO	Halozyme Therapeutics, Inc.	19,613	$1,535,109
4	VRTX	Vertex Pharmaceuticals Inc / Ma This page	1,989	$987,995
5	REGN	Regeneron Pharmaceuticals, Inc.	789	$491,973
6	INCY	Incyte Corp	2,120	$240,323
7	PRQR	ProQR Therapeutics N.V.	64,000	$119,040
8	ABVX	Abivax S.A.	643	$85,686

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$987,995	1,989	+19.5%	Shares	Sole	2026-07-15
2026-03-31	$743,489	1,665	+101.3%	Shares	Sole	2026-04-20
2025-12-31	$374,928	827	+44.8%	Shares	Sole	2026-02-03
2025-06-30	$254,209	571	-24.6%	Shares	Sole	2025-07-28
2025-03-31	$367,008	757	+12.1%	Shares	Sole	2025-04-09
2024-12-31	$271,822	675	-59.7%	Shares	Sole	2025-01-21
2024-09-30	$779,474	1,676	+17.0%	Shares	Sole	2024-10-17
2024-06-30	$671,207	1,432	+1.2%	Shares	Sole	2024-07-15
2024-03-31	$591,484	1,415	+30.5%	Shares	Sole	2024-04-11
2023-12-31	$441,068	1,084	+26.5%	Shares	Sole	2024-01-25
2023-09-30	$298,013	857	+2.6%	Shares	Sole	2023-10-16
2023-06-30	$293,844	835	+9.3%	Shares	Sole	2023-08-03
2023-03-31	$240,713	764	—	Shares	Sole	2023-05-09
No filing history on record for this holder in this stock.